Hindi siya nakakasira , nakakatulong pa siya sa sakit na kung tawagin ay NAFLD or non-alcoholic fatty liver disease. (Its not destructive, actually its the opposite
10.1016/j.cmet.2016.06.009 26
STEP-1: Semaglutide 2,4 mg, the standard since 2021 The STEP-1 trial (Wilding et al., NEJM 2021, PMID 33567185) randomized 1,961 overweight or obese adults (BMI 30 or BMI 27 with comorbidities) without diabetes to semaglutide 2,4 mg/week or placebo, with lifestyle interventions administered concurrently in both arms
Further research revealed its inhibitory effect on tyrosinase, an enzyme involved in melanin production, which highlighted its potential for hyperpigmentation and uneven tone
In addition, in non-obese diabetic mice, DPP-IV inhibitors significantly increase Treg expansion and TGF- level